1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
5
World xFund Allocation A
Fee
1.33%
ISIN
SE0015949904
Holdings
25
We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with World xFund Allocation A, we have 29 holdings where Camurus is the largest holding (7.84), followed by Novo Nordisk (5.54) and Palo Alto Networks (3.89).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and World xFund Allocation A.
| UBS Lux Equity Fund Biotech USD | World xFund Allocation A |
|---|---|
|
10.04 % |
 7.84 % |
|
9.21 % |
 5.54 % |
 4.66 % |
3.89 % |
|
4.13 % |
3.45 % |
|
3.75 % |
3.36 % |
| - |
2.97 % |
| - |
2.85 % |
| - |
2.81 % |
| - |
2.52 % |
| - |
2.5 % |
| - |
 2.48 % |
| - |
1.78 % |
| - |
1.52 % |
| - |
1.42 % |
| - |
1.41 % |
| - |
1.38 % |
| - |
1.38 % |
| - |
1.34 % |
| - |
1.26 % |
| - |
1.25 % |
| - |
1.24 % |
| - |
1.24 % |
| - |
 1.22 % |
| - |
1.22 % |
| - |
1.2 % |
The list of fund holdings was last updated on September 10, 2025.
